UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| 1 |
Starbucks
SBUX
|
$317M |
| 2 |
AGN
Allergan plc
AGN
|
$194M |
| 3 |
Charles Schwab
SCHW
|
$163M |
| 4 |
Pfizer
PFE
|
$136M |
| 5 |
3M
MMM
|
$126M |
Top Sells
| 1 |
ALTR
ALTERA CORP
ALTR
|
$316M |
| 2 |
Lexicon Pharmaceuticals
LXRX
|
$256M |
| 3 |
Intercontinental Exchange
ICE
|
$238M |
| 4 |
RKT
ROCK-TENN COMPANY CL-A
RKT
|
$136M |
| 5 |
Salesforce
CRM
|
$132M |
Sector Composition
| 1 | Healthcare | 17.28% |
| 2 | Financials | 14.69% |
| 3 | Technology | 14.3% |
| 4 | Consumer Discretionary | 9.55% |
| 5 | Industrials | 8.46% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Nike
NKE
$114B
| $663M | 0.63% | 6,138,744 +42,390 | +0.7% | +$4.58M |
|
27
Cisco
CSCO
$274B
| $650M | 0.62% | 23,685,000 +126,163 | +0.5% | +$3.46M |
|
|
28
Starbucks
SBUX
$100B
| $643M | 0.62% | 11,985,370 +5,912,824 | +97% | +$317M |
|
29
UnitedHealth
UNH
$281B
| $641M | 0.61% | 5,253,062 -2,328 | -0% | -$284K |
|
30
Merck
MRK
$210B
| $632M | 0.61% | 11,103,576 +391,219 | +4% | +$22.3M |
|
31
Amgen
AMGN
$155B
| $629M | 0.6% | 4,095,485 +30,418 | +0.7% | +$4.67M |
|
32
IBM
IBM
$227B
| $596M | 0.57% | 3,663,951 -169,376 | -4% | -$27.6M |
|
33
Mastercard
MA
$538B
| $587M | 0.56% | 6,274,720 +449,012 | +8% | +$42M |
|
34
Verizon
VZ
$186B
| $586M | 0.56% | 12,568,267 +68,224 | +0.5% | +$3.18M |
|
35
Intel
INTC
$107B
| $576M | 0.55% | 18,946,202 +250,544 | +1% | +$7.62M |
|
36
Coca-Cola
KO
$297B
| $547M | 0.52% | 13,944,775 +326,608 | +2% | +$12.8M |
|
37
AbbVie
ABBV
$372B
| $529M | 0.51% | 7,874,790 -1,755,164 | -18% | -$118M |
|
38
Schlumberger
SLB
$55B
| $511M | 0.49% | 5,930,293 +46,270 | +0.8% | +$3.99M |
|
39
CVS Health
CVS
$92.8B
| $511M | 0.49% | 4,872,649 +431,448 | +10% | +$45.3M |
|
40
TJX Companies
TJX
$152B
| $501M | 0.48% | 7,575,860 +591,269 | +8% | +$39.1M |
|
|
ESRX
41
DELISTED
Express Scripts Holding Company
ESRX
| $497M | 0.48% | 5,593,084 -6,928 | -0.1% | -$616K |
|
42
Oracle
ORCL
$635B
| $493M | 0.47% | 12,244,971 -22,395 | -0.2% | -$903K |
|
43
Philip Morris
PM
$260B
| $476M | 0.46% | 5,937,343 +86,663 | +1% | +$6.95M |
|
44
Thermo Fisher Scientific
TMO
$186B
| $476M | 0.46% | 3,667,295 +320,532 | +10% | +$41.6M |
|
45
Biogen
BIIB
$19.4B
| $471M | 0.45% | 1,166,412 -5,067 | -0.4% | -$2.05M |
|
|
46
3M
MMM
$82.8B
| $465M | 0.45% | 3,015,513 +816,379 | +37% | +$126M |
|
47
Booking.com
BKNG
$181B
| $454M | 0.43% | 394,154 -3,694 | -0.9% | -$4.25M |
|
48
American International
AIG
$45.1B
| $437M | 0.42% | 7,061,448 -543,740 | -7% | -$33.6M |
|
49
US Bancorp
USB
$76B
| $431M | 0.41% | 9,933,858 +2,921 | +0% | +$127K |
|
50
Qualcomm
QCOM
$173B
| $418M | 0.4% | 6,666,227 -174,595 | -3% | -$10.9M |
|